Mirae Asset Global Investments
TPST icon

Mirae Asset Global Investments’s Tempest Therapeutics TPST Stock Holding History

Mirae Asset Global Investments’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7
Closed -$562K – 481
2015
Q2 		$562K Buy
7
+1
+17% +$91.6K 0.02% 363
2015
Q1 		$612K Buy
+6
New +$799K 0.02% 358

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OH
Orbis Holdings Hamilton, Bermuda $12.8B AUM 8.29% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Mirae Asset Global Investments's TPST Position: Q3 2015 in Review

Mirae Asset Global Investments sold out of Tempest Therapeutics (TPST) in Q3 2015, closing a stake of 7 shares — an estimated $562K sold.

Mirae Asset Global Investments first reported a position in TPST in Q1 2015 and held it in 2 quarters. The position peaked at $612K in Q1 2015. 90 funds tracked by Wall St. Rank hold TPST as of Q3 2015.

  • Mirae Asset Global Investments reported no remaining Tempest Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Mirae Asset Global Investments sold 7 Tempest Therapeutics shares in Q3 2015, an estimated $562K.
  • Mirae Asset Global Investments first reported a position in Tempest Therapeutics in Q1 2015 and held it in 2 quarters.
  • Mirae Asset Global Investments's Tempest Therapeutics position peaked at $612K in Q1 2015.
  • 90 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2015.

Based on Mirae Asset Global Investments's 13F filing for Q3 2015, filed 12 Nov 2015.